Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $15.36M | $15.21M | $67.88M | $19.30M | $14.89M |
| Selling and Admin Expenses | $5.65M | $5.84M | $21.17M | $5.56M | $5.82M |
| -General & Admin Expense | $5.65M | $5.84M | $21.17M | $5.56M | $5.82M |
| Research & Development | $9.71M | $9.37M | $46.71M | $13.74M | $9.07M |
| Operating Profit | -$15.36M | -$15.21M | -$67.88M | -$19.30M | -$14.89M |
| Net Non-Operating Interest Income (Expense) | $1.86M | $1.51M | $8.32M | – | – |
| Non-Operating Interest Income | $1.86M | $1.51M | $8.32M | – | – |
| Other Income (Expense) | $6,000.00 | -$25,000.00 | -$291,000.00 | -$6.54M | $2.00M |
| Gain on Sale of Security | $6,000.00 | -$25,000.00 | -$291,000.00 | -$46,000.00 | -$33,000.00 |
| Pretax Profit | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| Net Profit | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| Profit from Continuing Operations | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| Net Income to Parent Company | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| Net Income to Common Stockholders | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| Basic EPS | -$0.18 | -$0.20 | -$0.88 | -$0.26 | -$0.19 |
| Diluted EPS | -$0.18 | -$0.20 | -$0.88 | -$0.26 | -$0.19 |
| Special Income (Charges) | – | – | $0.00 | $0.00 | $0.00 |
| Other Non-Operating Income (Expenses) | – | – | – | – | $2.04M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $246.29M | $152.37M | $167.74M | $167.74M | $182.30M |
| Total Current Assets | $186.64M | $113.40M | $105.85M | $105.85M | $90.96M |
| Cash and Cash Equivalents & Short-Term Investments | $183.12M | $109.56M | $101.08M | $101.08M | $86.90M |
| -Cash and Cash Equivalents | $44.11M | $8.36M | $35.69M | $35.69M | $25.80M |
| -Short Term Investments | $139.02M | $101.21M | $65.40M | $65.40M | $61.10M |
| Prepaid Assets | $3.51M | $3.84M | $4.77M | $4.77M | $4.06M |
| Total Non-Current Assets | $59.66M | $38.97M | $61.90M | $61.90M | $91.34M |
| Net PPE | $1.91M | $697,000.00 | $793,000.00 | $793,000.00 | $880,000.00 |
| -Gross PPE | $1.91M | $697,000.00 | $793,000.00 | $793,000.00 | $880,000.00 |
| Investments and Advances | $56.10M | $36.74M | $59.57M | $59.57M | $88.93M |
| -Available for Sale Securities | $56.10M | $36.74M | $59.57M | $59.57M | $88.93M |
| Other Non-Current Assets | $1.65M | $1.53M | $1.53M | $1.53M | $1.53M |
| Total Liabilities | $6.75M | $4.29M | $7.27M | $7.27M | $5.30M |
| Total Current Liabilities | $5.93M | $4.07M | $6.98M | $6.98M | $4.95M |
| Payables | $1.13M | $860,000.00 | $2.27M | $2.27M | $477,000.00 |
| -Accounts Payable | $1.13M | $860,000.00 | $2.27M | $2.27M | $477,000.00 |
| Current Accrued Expenses | $4.01M | $2.84M | $4.40M | $4.40M | $4.17M |
| Short-Term Debt and Capital Lease Obligation | $501,000.00 | $263,000.00 | $256,000.00 | $256,000.00 | $228,000.00 |
| -Current Capital Lease Obligation | $501,000.00 | $263,000.00 | $256,000.00 | $256,000.00 | $228,000.00 |
| Other Current Liabilities | $295,000.00 | $113,000.00 | $59,000.00 | $59,000.00 | $77,000.00 |
| Total Non-Current Liabilities | $813,000.00 | $216,000.00 | $285,000.00 | $285,000.00 | $352,000.00 |
| Long Term Debt and Capital Lease Obligation | $813,000.00 | $216,000.00 | $285,000.00 | $285,000.00 | $352,000.00 |
| -Long Term Capital Lease Obligation | $813,000.00 | $216,000.00 | $285,000.00 | $285,000.00 | $352,000.00 |
| Total Equity | $239.55M | $148.09M | $160.48M | $160.48M | $177.00M |
| Stockholders' Equity | $239.55M | $148.09M | $160.48M | $160.48M | $177.00M |
| Capital Stock | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $7,000.00 |
| -Common Stock | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $7,000.00 |
| Additional Paid-In Capital | $556.56M | $451.37M | $449.76M | $449.76M | $448.74M |
| Retained Earnings | -$316.95M | -$303.45M | -$289.73M | -$289.73M | -$272.21M |
| Gains/Losses Not Affecting Retained Earnings | -$67,000.00 | $157,000.00 | $435,000.00 | $435,000.00 | $469,000.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$10.55M | -$14.38M | -$54.36M | -$15.64M | -$12.14M |
| Net cash flow from continuing operations | -$10.55M | -$14.38M | -$54.36M | -$15.64M | -$12.14M |
| Net Income from Continuing Operations | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| Gain/Loss from Continuing Operations | -$16,000.00 | $21,000.00 | $18,000.00 | -$5,000.00 | -$1,000.00 |
| Depreciation & Depletion & Amortization | $33,000.00 | $38,000.00 | $97,000.00 | $30,000.00 | $29,000.00 |
| Other Non-Cash Items | -$1,000.00 | $58,000.00 | $201,000.00 | $57,000.00 | $56,000.00 |
| Change in Working Capital | $1.84M | -$2.07M | -$601,000.00 | $1.27M | -$2.79M |
| -Change in Prepaid Assets | $327,000.00 | $929,000.00 | -$816,000.00 | -$706,000.00 | -$1.38M |
| -Change in Payables and Accrued Expense | $1.14M | -$2.94M | $1.94M | $2.01M | -$1.19M |
| -Change in Other Current Assets | $304,000.00 | $0.00 | -$1.51M | $0.00 | -$162,000.00 |
| -Change in Other Current Liabilities | $67,000.00 | -$62,000.00 | -$207,000.00 | -$39,000.00 | -$59,000.00 |
| Net cash flow from investing | -$57.26M | -$12.96M | $2.83M | $25.54M | $15.26M |
| Net Cash Flow from Continuing Investing Activities | -$57.26M | -$12.96M | $2.83M | $25.54M | $15.26M |
| Net Investment Purchase and Sale | -$57.00M | -$12.96M | $3.02M | $25.54M | $15.37M |
| Financing Cash Flow | $103.70M | $5,000.00 | -$21,000.00 | -$21,000.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | $103.70M | $5,000.00 | -$21,000.00 | -$21,000.00 | $0.00 |
| Proceeds from Stock Option Exercised | $335,000.00 | $5,000.00 | $65,000.00 | $65,000.00 | $0.00 |
| Ending Cash Balance | $44.25M | $8.36M | $35.69M | $35.69M | $25.80M |
| Net Change in Cash | $35.89M | -$27.33M | -$51.54M | $9.88M | $3.12M |
| Beginning Cash Balance | $8.36M | $35.69M | $87.23M | $25.80M | $22.68M |
| Effect of Exchange Rate Changes | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free Cash Flow | -$10.81M | -$14.38M | -$54.54M | -$15.64M | -$12.25M |
| Net PPE Purchase and Sale | – | – | -$186,000.00 | $0.00 | -$109,000.00 |
| Net Common Stock Issuance | – | – | $0.00 | $0.00 | $0.00 |
| Net Other Financing Charges | – | – | -$86,000.00 | – | – |
No comments yet — be the first to weigh in on CLYM.